195 related articles for article (PubMed ID: 31229551)
21. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
23. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
24. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt.
Sun Z; Zhang L; Li L; Shao C; Liu J; Zhou M; Wang Z
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H364-H380. PubMed ID: 33275526
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.
Egashira I; Takahashi-Yanaga F; Nishida R; Arioka M; Igawa K; Tomooka K; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Kitazono T; Sasaguri T
Cancer Sci; 2017 Jan; 108(1):108-115. PubMed ID: 27761963
[TBL] [Abstract][Full Text] [Related]
29. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
30. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
[TBL] [Abstract][Full Text] [Related]
31. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
32. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
[TBL] [Abstract][Full Text] [Related]
33. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
[TBL] [Abstract][Full Text] [Related]
34. The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
Savergnini SQ; Ianzer D; Carvalho MB; Ferreira AJ; Silva GA; Marques FD; Peluso AA; Beiman M; Cojocaru G; Cohen Y; Almeida AP; Rotman G; Santos RA
PLoS One; 2013; 8(3):e57757. PubMed ID: 23469229
[TBL] [Abstract][Full Text] [Related]
35. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
[TBL] [Abstract][Full Text] [Related]
37. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.
Honda Y; Shishido T; Takahashi T; Watanabe T; Netsu S; Kinoshita D; Narumi T; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Kishida S; Kadomatsu K; Takeishi Y; Kubota I
Hypertension; 2016 May; 67(5):857-65. PubMed ID: 26975703
[TBL] [Abstract][Full Text] [Related]
38. Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy.
Buss SJ; Riffel JH; Malekar P; Hagenmueller M; Asel C; Zhang M; Weiss C; Katus HA; Hardt SE
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H420-30. PubMed ID: 22058151
[TBL] [Abstract][Full Text] [Related]
39. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
Ma ZG; Zhang X; Yuan YP; Jin YG; Li N; Kong CY; Song P; Tang QZ
Clin Sci (Lond); 2018 Mar; 132(6):685-699. PubMed ID: 29540538
[TBL] [Abstract][Full Text] [Related]
40. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]